| Weekly low‐dose versus three‐weekly high‐dose cisplatin for concurrent chemoradiation in locoregionally advanced non‐nasopharyngeal head and neck cancer: a systematic review … P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... The oncologist 22 (9), 1056-1066, 2017 | 177 | 2017 |
| Treatment landscape of metastatic pancreatic cancer S De Dosso, AR Siebenhüner, T Winder, A Meisel, R Fritsch, C Astaras, ... Cancer treatment reviews 96, 102180, 2021 | 123 | 2021 |
| Treatment of elderly patients with squamous cell carcinoma of the head and neck P Szturz, JB Vermorken Frontiers in oncology 6, 199, 2016 | 96 | 2016 |
| Obecná onkologie Z Adam, M Krejčí, J Vorlíček, Z Adamová, J Bačovský, V Bajčiová, ... Galén, 2011 | 96 | 2011 |
| Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... Frontiers in oncology 9, 86, 2019 | 93 | 2019 |
| Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy D Evrard, P Szturz, A Tijeras-Raballand, L Astorgues-Xerri, C Abitbol, ... Oral oncology 88, 29-38, 2019 | 83 | 2019 |
| Immunotherapy in head and neck cancer: aiming at EXTREME precision P Szturz, JB Vermorken BMC medicine 15, 1-11, 2017 | 81 | 2017 |
| Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer: recommendations for clinical practice P Szturz, V Cristina, RG Herrera Gómez, J Bourhis, C Simon, ... Frontiers in oncology 9, 464, 2019 | 76 | 2019 |
| Understanding c-MET signalling in squamous cell carcinoma of the head & neck P Szturz, E Raymond, C Abitbol, S Albert, A De Gramont, S Faivre Critical reviews in oncology/hematology 111, 39-51, 2017 | 63 | 2017 |
| Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher P Szturz, JB Vermorken Oral oncology 101, 104492, 2020 | 62 | 2020 |
| Contrast-enhanced ultrasonography compared to gray-scale and power doppler in the diagnosis of peripheral lymphadenopathy R Slaisova, K Benda, J Jarkovsky, H Petrasova, P Szturz, V Valek European journal of radiology 82 (4), 693-698, 2013 | 48 | 2013 |
| Immunotherapies and future combination strategies for head and neck squamous cell carcinoma V Cristina, RG Herrera-Gómez, P Szturz, V Espeli, M Siano International journal of molecular sciences 20 (21), 5399, 2019 | 44 | 2019 |
| Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... Oral oncology 76, 52-60, 2018 | 41 | 2018 |
| Onkologie J Vorlíček, J Abrahámová, V Bajčiová, T Büchler, M Doubek, F Folber, ... Triton, 2012 | 35 | 2012 |
| Translating KEYNOTE-048 into practice recommendations for head and neck cancer P Szturz, JB Vermorken Annals of translational medicine 8 (15), 2020 | 32 | 2020 |
| Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer R Saesen, M Van Hemelrijck, J Bogaerts, CM Booth, JJ Cornelissen, ... European Journal of Cancer 186, 52-61, 2023 | 31 | 2023 |
| Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data P Szturz, M Budíková, JB Vermorken, I Horova, B Gál, E Raymond, ... Oral oncology 74, 68-76, 2017 | 30 | 2017 |
| Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice P Szturz, P Bossi, JB Vermorken Current opinion in otolaryngology & head and neck surgery 27 (2), 142-150, 2019 | 28 | 2019 |
| Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment P Szturz, Z Adam, V Vašků, J Feit, M Krejčí, L Pour, R Hájek, J Mayer Leukemia & lymphoma 54 (6), 1324-1326, 2013 | 27 | 2013 |
| Gemcitabine-based chemoradiation in the treatment of locally advanced head and neck cancer: systematic review of literature and meta-analysis OM Vanderveken, P Szturz, P Specenier, MC Merlano, M Benasso, ... The oncologist 21 (1), 59-71, 2016 | 26 | 2016 |
